We conclude based on our observations of BKM120 treatment in canine lymphoma and experiments using SUDHL4, as well as our predictions based on TcB analysis of human tumors, that the progression of malignant tumours can be characterized by a sequence of transcriptomic changes relating to protein transcription, replication, and translation. This evidence concerns the gene PKM and neoplasm.